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The presence of heart-specific autoantibodies in the sera of some patients with 
Coxsackievirus B.~ (CB3)l-induced myocarditis (1,  2) has suggested that autoim- 
munity is  a  sequela  of viral  myocarditis. Similar  heart-specific autoantibodies 
have previously been found in patients with poststreptococccal rheumatic fever 
(3), Chagas' disease (4, 5), postpericardiotomy syndrome (6, 7) and post-myocar- 
dial infarction syndrome (6, 7). However, the human disease does not easily lend 
itself to study due to the rarity of the disease and the unknown time course of 
the original viral infection. Therefore, an animal model is extremely valuable. 
Several murine models of myocarditis have been developed to investigate the 
pathogenic mechanisms involved in  CB3-induced myocarditis. One  model de- 
scribed by the Woodruffs (8) has allowed for the study of cytotoxic T lymphocytes 
(CTL) that are generated in response to the viral infection. It has been demon- 
strated  (9,  10)  that  these  CTL  can  damage  myocardial cells  in  vitro.  These 
studies have  suggested that this cell-mediated response  is a  major pathogenic 
mechanism in CB~ myocarditis in adult male BALB/c mice. Huber and Lodge 
(1 1) have found that two populations of CTL are produced during this disease 
in  mice.  One population is virus-specific, and preferentially lyses infected my- 
ocytes, while the second preferentially lyses  uninfected myocytes. This second 
"autoreactive" CTL population indicates that cellular autoimmunity may play an 
important role in the development of  myocarditis. A second model was developed 
(12), and was used for the identification of factors that may influence the severity 
of the disease, such as drug therapy, age, and exercise. The second model differs 
from the first in the strains and age of the mice used; sex does not appear to be 
influential. Furthermore, the CB3 infection resulted in chronic, dilatational heart 
disease similar to that seen in humans. This model of CB3-induced myocarditis 
was the starting point of this study. 
Here, we report the discovery of heart-specific autoantibodies in suckling mice 
following infection with CB3, corresponding with the development of myocar- 
ditis. This finding provides an opportunity to study the development and rele- 
This work was supported by U. S. Public Health Service grants HL-27932, HL-30144, and CA- 
34202 from the National Heart, Lung,  and Blood  Institute,  and from the National  Cancer Institute. 
Present address of L. J.  Wolfgram: Hahnemann University, Department of Microbiology and 
hnmunology,  Philadelphia, PA, 19102. 
Abbreviations used in this paper:  AFA,  antifibrillary  antibodies; ANA, antinuclear antibodies; 
ASA, antisarcolemmal antibodies; ASMA, anti-smooth muscle antibodies; CB~, Coxsackievirus B~; 
CTL, cytotoxic T lymphocyte;  FITC, fluorescein isothiocyanate; MHC, major histocompatibility 
complex. 
1 1 1  2  J. ExP. MED. © The Rockefeller  University  Press • 0022-1007/85/5/1112110  $1.00 
Volume 161  May 1985  1112-1121 WOLFGRAM  ET  AL.  1 1 13 
vance of these heart-specific autoantibodies  in  myocarditis and to delineate  the 
corresponding cardiac antigen(s). 
Materials and  Methods 
Infection  and Necropsy.  2-wk-old female A.SW/SnJ (H-2 ~) mice (The Jackson Labora- 
tory, Bar Harbor, ME)  were injected  intraperitoneally with  0.1  ml  105  tissue-infective 
dose50 (TCIDs0) CB3 (Nancy strain). The mice were killed by retroorbital bleeding at days 
2, 3, 5, 7, 9, 15, 21, and 45 postinfection. The serum from individual animals was collected 
and stored at -70°C  until tested.  Control animal sera were prepared similarly, except 
that the animals were inoculated with an uninfected Vero monkey kidney cell  culture 
(Flow Laboratories, Inc., McLean, VA) lysate identical to the culture used to prepare the 
virus. 
Histology.  The hearts were fixed in  10%  buffered formalin,  sectioned,  and  stained 
with hematoxylin-eosin according to standard procedures. The slides were then examined 
for evidence of myocarditis. 
Indirect Immunofluorescence.  The method used is that of Bigazzi and Rose (13).  The 
heart, kidney, liver, and stomach were removed from an uninfected animal, frozen, and 
4 um sections were cut in a cryotome. The sections were overlaid with a  1:10 dilution of 
mouse serum, and incubated at room temperature for 30 min. The slides were rinsed, 
and washed for 30  rain  in  phosphate-buffered saline, pH 7.2.  Next,  the sections were 
incubated  30  rain  at room temperature with  either fluorescein  isothiocyanate (FITC)- 
conjugated goat anti-mouse Ig (Cappel Laboratories, Cochranville, PA), FITC-conjugated 
goat anti-mouse IgG (Tago Inc., Burlingame, CA), or FITC-conjugated goat anti-mouse 
IgM (Cappel Laboratories). The slides were then rinsed, and washed for 30 min in PBS. 
Following this final wash,  the  sections were overlaid with  90%  (vol/vol) glycerol/PBS, 
coverslipped, and examined using a Zeiss fluorescent microscope. 
Absorption Studies.  Organs were prepared according to a modification of McCabe et 
al. (14).  Briefly, the heart, kidney, liver, and skeletal muscle (gastrocnemius) from 30-50 
mice of various strains were rinsed free of blood in cold borate-buffered saline, pH 8.0. 
The organs were homogenized, centrifuged at 200 g for  10 rain, and washed until the 
supernatant  was  clarified.  The  pellet  was  saved  as  the  insoluble  fraction.  The  initial 
supernatant and all washes were pooled and centrifuged at 16,300 g at 4°C for 1 h. The 
pellet from the high speed spin was saved as the microsomal fraction, and the supernatant 
was designated the soluble fraction. Each of the three fractions from the four organs was 
dialyzed, lyophilized, and then  mixed (4  rag) with 0.1  ml of diluted  (1:10) serum. The 
mixture was incubated for 1 h at room temperature. Following incubation, the mixture 
was centrifuged for 10 rain in a microfuge. The supernatant was removed and used in an 
indirect immunofluorescence assay, as described above. 
Results 
The sera from 59 A.SW mice that had been infected with CB3 were tested on 
normal mouse tissues in indirect immunofluorescence assays. Sera taken at days 
2 and 3 after infection were not tested due to lingering virus presence. Infected 
and  control animal sera were sampled at days 5,  7,  9,  15,  21,  and  45.  At days 
15,  21,  and  45  after infection,  heart-reactive autoantibodies  could be detected 
in  the  animals,  in  various  degrees  of  incidence  and  titer.  No  heart-reactive 
antibodies were found in any animals before day  15 after infection.  All control 
animals  were  negative  for  heart-reactive  antibodies.  The  prevalence  of  the 
antibodies  decreased  from  day  15  to  day  45.  Heart-reactive  antibodies  were 
found in 78% (7 of 9) of the animals at day 15, in 50% (4 of 8) of the animals at 
day 21,  and in  40%  (4 of 10) of the animals at day 45  postinfection.  Although 
the incidence decreased, there was, among animals that developed antibodies, a 1114  HEART-SPECIFIC  AUTOANTIBODIES 
trend toward higher titer; from 30 +_ 9 (mean +  SE) at day 15, to 28 +  8 at day 
21, and 85  +  29 at day 45. All of the antibodies seen were of the IgG isotype. 
No IgM antibodies were identified in any of the heart-reactive sera. This may be 
due either to the possibility that the IgM antibodies appeared briefly between 
our sample times of days 9 and 15, or that they are all absorbed out by the heart 
of the donor animal. Thus, A.SW mice will produce myocardial autoantibodies 
as a sequela to CBs infection. 
Several patterns of immunofluorescent localization could be distinguished with 
the sera from the CBs-infected animals (Fig. 1). The first pattern delineated was 
a reaction with the myocyte membranes (Fig.  1  A). These antibodies have been 
termed antisarcolemmal antibodies (ASA) and were similar to those described in 
human postvirai  myocarditis (1,  2),  rheumatic carditis (3),  postpericardiotomy 
(6,  7), and post-myocardial infarction (6,  7) syndromes. All  15 animals positive 
for heart-reactive antibodies demonstrated this reaction.  The second reaction 
was with one or more of the intracellular contractile proteins, which may include 
actin and myosin (Fig.  1, B and C). These autoantibodies may be similar to the 
antifibrillary antibodies  (AFA)  as  described  by  Maisch  et  al.  (1)  in  postviral 
myocarditis. In the sera from animals with ASA, 8 of 15 were also positive for 
these antibodies. 
An additional reaction was seen only at day 45 in three of four animals that 
displayed the myocardial autoantibodies. These three sera had a focal reaction 
with kidney tubules (Fig.  1 D).  Maisc]a et al. (2) have described a  heterologous 
renal tubular pattern that was attributed to heterophile antibodies. Non-organ- 
specific autoantibodies, such as anti-smooth muscle antibodies (ASMA) and anti- 
nuclear antibodies (ANA) were also observed.  The ASMA were found in 8  of 
15 of the animals with heart antibodies, and in 5 of 12 of the animals without 
heart antibodies. No ASMA were detected in the 15 control animals tested. Only 
one of the  infected animals demonstrated ANA,  and  it was  negative for the 
heart-reactive antibodies. However, 5 of the 15 control animals were positive for 
ANA.  Reactivity with  skeletal  muscle  was  present  in  3  of  12  antimyocardial 
antibody-negative sera, and in  12 of 15 antimyocardial antibody-positive sera. 
Titration  experiments  showed that  this  latter  reaction  was  generally one-  to 
twofold weaker in titer than that with heart muscle. The titration results from 
several animals at the various sample times are shown in Table  I.  Therefore, 
A.SW animals develop both organ-specific as well as non-organ-specific auto- 
antibodies after infection with CBs. 
Absorptions were done in an effort to determine whether the autoantibodies 
were indeed heart-specific, as well as  to identify whether soluble or  insoluble 
antigens were  involved.  Soluble  and  insoluble  fractions  were  prepared  from 
heart,  skeletal  muscle,  kidney, and  liver.  Sera  were  absorbed  with individual 
fractions from each of the organs, as well as a  mixture of the fractions. Results 
from a representative absorption experiment are given in Table II. These results 
were obtained by absorbing separate samples of the serum with each insoluble 
organ  fraction.  The  insoluble  fraction of the  heart  homogenate was  able  to 
absorb out all reactivity from the sera with the heart, skeletal muscle, and kidney. 
The microsomal fraction and the soluble fraction of heart only diminished the 
heart reaction slightly, and had little or no effect on the skeletal muscle or kidney WOLFGRAM  ET  AL.  1115 
FIGURE  1.  Indirect immunofluorescent staining  of normal murine heart and kidney tissues 
with sera  from A.SW/SnJ animals  15 and 45 d after infection with CBs. (A) Reactivity  with 
myocyte  membrane was observed in  a  serum  that  was  diluted  1:10. The serum  used  was 
obtained  from  animal  6,  which  was  killed  15  d  after  infection.  This  reaction  pattern  is 
representative of ASA. (B) A serum that was diluted 1:40 was obtained from animal 3 at 15 d 
after infection.  The pattern  depicted was  that  of a  fine striated  contractile band  reaction 
observed in heart tissue. (C) A wider striation  band reaction was seen with serum (diluted  1:10) 
from animal  1, 45  d after CB~ infection. Reactions  seen  in B and C have been collectively 
termed AFA, since they appear to be reactive with one or more of the intracellular contractile 
proteins. (D) A focal kidney tubule reaction was found in the serum from the same animal (1) 
shown in C. 
reactivity.  As  with  the  heart,  the  primary  reacting  antigen(s)  in  the  skeletal 
muscle and kidney could be found in the insoluble fraction. The kidney insoluble 
fraction could only absorb out the kidney reaction. The  skeletal muscle insoluble 
fraction totally removed all skeletal muscle reactivity, but only slightly diminished 
the antimyocardial titer. 
All of the sera that demonstrated  some reactivity to heart were absorbed with 
the skeletal muscle insoluble fraction. The  results of these absorptions are found 1116  HEART-SPECIFIC  AUTOANTIBODIES 
TABLE  I 




Animal  Heart  Skeletal Muscle 
ASA  AFA  ASA  AFA 




1  20  0  0  0  0  0 
2  20  20  0  0  0  0 
3  40  40  20  10  0  0 
4  80  80  40  0  0  0 
5  20  0  20  10  0  0 
6  20  0  10  0  0  0 
10  10  0  I0  0  0  0 
2  40  40  40  40  0  0 
7  10  10  10  0  0  0 
8  40  40  20  20  0  0 
9  20  20  20  20  0  0 
1  80  80  40  40  80  0 
5  20  2O  10  10  0  0 
8  80  80  80  80  80  0 
10  160  160  40  40  160  0 
* The antibody titer is expressed as the reciprocal of last dilution that shows a positive reaction. 
TABLE  II 
Absorption of Autoantibodies*  with the Insoluble Fraction of Organ 
Homogenates 
Tissue reaction* 
Absorbing organ  Heart  Skeletal Muscle 
ASA  AFA  ASA  AFA 
Kidney  Liver 
Unabsorbed  4  4  3  2  3  0 
Liver  4  4  3  2  3  0 
Kidney  4  4  3  2  0  0 
Skeletal Muscle  2  2  0  0  3  0 
Heart  0  0  0  0  0  0 
* Serum, obtained from A.SW animal 8  45 d  after infection, was used at  l:10 
dilution. 
* Tissue reaction was determined by indirect immunofluorescence. The intensity 
of fluorescence observed was graded on a 0-4 scale. 
in  Table  1II.  Several  sera  that  reacted  only  with  skeletal  muscle  were  also 
absorbed  in a  similar  manner.  In all but  one  serum,  the  skeletal muscle  fraction 
was  able  to  remove  the  skeletal  muscle  antibodies  while  not  removing  or  only 
slightly  diminishing  the  heart  reaction.  Absorption  with  the  skeletal  muscle 
fraction  had  no effect on the antibodies  that reacted  with kidney.  However,  there 
were  various  effects on  the anti-smooth  muscle  antibodies  in these sera.  In some 
sera,  the  ASMA  were  only  lessened,  while  in  other  sera,  the  ASMA  could  be 
completely  removed.  To  make  certain  that  the  inability  of  the  skeletal  muscle 
fraction  to  remove  the  heart  reaction  was  not  simply  a  quantitative  difference, WOLFGRAM  ET  AL.  1117 
TABLE  III 




Animal  Heart  Skeletal Muscle 
ASA  AFA  ASA  AFA 
Smooth 




1  2  (1)*  1 (1)  2  (0)  1 (0)  0  0 
2  2 (1)  2 (1)  1 (0)  1 (0)  0  1 (0) 
3  3 (3)  3 (3)  3 (o)  3 (o)  o  1 (1) 
4  4 (2)  4 (2)  2 (0)  1 (0)  0  1 (0) 
5  3 (2)  3 (2)  1 (1)  1 (1)  0  2 (0) 
6  3 (2)  3 (2)  2 (0)  2 (0)  0  3 (2) 
7  2 (0)  2 (0)  2 (0)  1 (0)  0  1 (1) 
9  2 (0)  2 (0)  1 (0)  1 (0)  0  3 (2) 
10  2 (1)  2 (1)  2 (0)  2 (0)  0  2 (0) 
I  2  (0)  1 (0)  2  (0)  2 (0)  0  1 (1) 
7  1 (1)  1 (1)  0  1 (0)  0  0 
8  2  (1)  2  (1)  3 (0)  2  (0)  0  0 
9  3 (3)  3 (3)  2 (0)  2 (0)  0  2 (1) 
lo  1 (o)  1 (o)  1 (o)  o  o  o 
1  4  (3)  4  (3)  3 (0)  3 (0)  2  (2)  0 
3  2 (0)  0  2  (0)  1 (0)  0  1 
5  2  (2)  2  (1)  1 (0)  2 (0)  0  3 
6  2 (0)  1 (0)  2 (0)  2 (0)  0  0 
8  3 (2)  3 (2)  3 (0)  2  (0)  3 (3)  0 
10  3 (2)  2 (2)  3 (0)  1 (0)  2  (3)  0 
(0) 
(1) 
* Tissue reaction was determined by indirect immunofluorescence and the intensity of fluorescence 
observed was graded on a 0-4 scale. 
* The  first  score  represents  the  tissue  reactivity  before  absorption  and  the  score  in  parenthesis 
represents the tissue reactivity after absorption. 
the absorption  with the  skeletal  muscle fraction  was repeated  sequentially  three 
times. No further  decrease  in the heart reaction  was noticed.  The  liver fractions 
had no effect on any of the reactions,  and therefore  served as a  negative control. 
Thus,  these  experiments  demonstrated  that  the  heart-reactive  antibodies  were 
indeed  heart-specific,  and  distinct  from  the  antibodies  that  crossreacted  with 
kidney and  skeletal muscle. 
The  autoantibody-containing  sera were also tested  on normal  rat and baboon 
tissues.  The  reactions  identical  to those in mouse tissue were found  with rat and 
baboon  heart  and  skeletal  muscle.  However,  the  heterogeneous  kidney  tubule 
reaction  was  found  with  the  rat  kidney,  but  not  with  the  baboon  kidney.  The 
absorptions  with  the  murine  organ  fractions also removed  the reactions  against 
the  rat  and  baboon  tissues.  Therefore,  these  heart  autoantibodies  are  organ- 
specific,  but neither  heterophile  in nature,  nor species specific.  It appeared  that 
the  skeletal  muscle  crossreaction  was also  not  species  specific,  while  the  kidney 
tubule  reaction  was rodent  specific. 
Pathological  findings  in  the  A.SW  hearts  after  day  9  consisted  of large  focal 
lesions  containing  lymphocytes,  polymorphonuclear  neutrophils,  and  macro- 
phages.  In addition,  an  interstitial  infiltrate  composed  of large and small  mono- 1118  HEART-SPECIFIC  AUTOANTIBODIES 
nuclear cells was observed. All of the 15 animals that demonstrated these heart- 
specific autoantibodies  also had  some evidence of myocardial  damage.  These 
animals  showed evidence of an  ongoing  inflammatory  process,  with  the  peak 
occurring at day 15. As determined by an analysis of variance test, there was no 
correlation  between the severity of the  myocardial involvement at the time of 
necropsy and the presence, titer, and/or reactivity pattern of the autoantibodies, 
as shown in Table IV. Therefore, these autoantibodies indicated that myocardial 
damage had occurred, but neither their presence, reactivity, nor titer indicated 
the degree of damage at the time they were found. 
Discussion 
We  describe  the  first  animal  model  of post-CB3  myocarditis  where  heart- 
specific autoantibodies are produced. Similar autoantibodies have been described 
by  Maisch  and  coworkers  (1,  2)  in  patients  with  post-CB  myocarditis.  The 
autoantibodies appear to be directed mainly against the membrane  or a  mem- 
brane-bound antigen.  Further  work in our laboratory is underway to identify 
the antigen(s) against which these autoantibodies are directed.  Whether or not 
these  heart-specific  autoantibodies  are  mediators  of  damage  remains  to  be 
determined.  We have examined other  mouse strains,  in addition  to the A.SW 
inbred  strain  used  in  this  study  (Wolfgram,  Beisel,  Herskowitz,  and  Rose, 
submitted for publication).  Heart-specific autoantibodies were found in all four 
of the congenic strains with the A background, regardless of their H-2 haplotype, 
and all developed the typical ongoing myocarditis. In contrast, none of the B 10 
TABLE  IV 
Correlation of the Autoantibody Titer with Severity of Myocardial 
Lesions 
Days after infec-  Animal  Heart-specific anti-  Pathological 
tion  body titer  index* 
15  1  20/0*  1.2 
2  20  1.0 
3  40  3.8 
4  80  2.5 
5  20/0  1.5 
6  20/0  2.2 
10  40  3.0 
21  2  40  1.0 
7  10  1.0 
8  40  1.8 
9  20  3.8 
45  1  80  0.8 
5  20  1.0 
8  80  2.5 
10  160  0.5 
* The  pathological index  is  a  mean  of the scores (0-4)  given by  two 
independent observers. 
* The titer of ASA/AFA reactivity. If the serum had identical titers for 
both reaction patterns, then only one titer is given. WOLFGRAM ET  AL.  1 1 19 
congenics produced these autoantibodies, and none showed chronic myocardial 
inflammation.  Besides the non-MHC (major histocompatibility complex)-regu- 
lated predisposition,  an MHC influence was noted in the observed variation of 
incidence and autoantibody titer among the four A-background H-2 congenics. 
Further  investigations  will  determine  the  genetic~parameters  that  control  the 
predisposition  to  the  production  of these  heart-specific  autoantibodies  and  to 
ongoing myocarditis. 
Correlation between an infectious disease and the induction of an autoimmune 
disease has been investigated in several systems (14,  15). The possibility of a viral 
etiologic agent has been postulated in diseases such as juvenile diabetes mellitus 
(15)  and  postmeasles  encephalitis  (16).  However,  proving  that  a  virus  is  the 
primary etiologic agent  is a  difficult task in  the human  situation  because viral 
isolations are rare  and,  usually,  the  only connection  is the clinical  history and 
rising antiviral antibody titers. Therefore, a suitable animal model will prove to 
be crucial  for establishing  a  causative relationship  between autoimmunity and 
viral myocarditis. 
There  are several current  hypotheses that could explain  the development of 
these antibodies.  First,  the immunofluorescent reaction with frozen heart tissue 
indicates that some normal heart antigen(s) may be the target.  Infection and/or 
inflammation  may render heart components antigenic.  This situation  has been 
hypothesized by Szarfman  et al.  (4) in Chagas'  disease following infection with 
Trypanosoma  cruzi. A  second  hypothesis  is  that  antiviral  antibodies  elicited by 
CB3  may crossreact with a  normal  heart  antigen.  A  similar  situation  has  been 
found in poststreptococcal rheumatic fever (3,  17), and has been reported (5) in 
Chagas' disease. A third hypothesis is that CB~ induces a myocardial neoantigen 
(18) to which antibodies are produced. Our finding that the autoantibodies react 
with normal heart tissue makes this possibility less likely. A  more recent theory 
holds that autoantibodies may be antiidiotypic antibodies against antiviral  anti- 
bodies that  may react with the viral receptor (19,  20).  All of these possibilities 
are currently under examination. 
Since our demonstration  of autoantibodies against cardiac tissue indicates the 
development of an autoimmune  process, the question of autoimmunity and  its 
importance  in  the  pathogenesis  of virally  induced  myocardial  injury  must  be 
raised. Potentially, autoimmunity can develop in genetically predisposed individ- 
uals  whenever  damage  is  done  to  the  cardiac  tissue.  This  can  occur  with  a 
bacterial, viral, or parasitic  infection, after open-heart surgery, or after a  myo- 
cardial  infarction.  Therefore,  this  murine  model  CBs-induced myocarditis can 
be used to investigate the genetic predisposition,  cellular, and humoral  mecha- 
nisms, and perhaps possibilities for treatment  for cardiac autoimmunity in post- 
viral myocarditis. The first step necessary in these investigations is to isolate the 
antigenic target and demonstrate that it is capable of initiating an immunopath- 
ological  reaction.  The  availability  of autoantibodies  in  postinfection  sera  will 
permit us to identify the antigen(s) responsible. 
Summary 
The  sera  from  A.SW/SnJ  mice  infected with  Coxsackievirus B3 (CBs) were 
tested on normal  mouse tissue by indirect immunofluorescence.  Heart-reactive 1120  HEART-SPECIFIC  AUTOANT1BODIES 
antibodies were found.  Absorption studies with organ extracts showed some of 
these autoantibodies to be heart-specific. Additional antibodies were crossreactive 
with skeletal muscle and kidney. These findings suggest a role for autoimmunity 
in  the  pathogenesis  of murine  CB~-induced  myocarditis.  This study establishes 
an animal model for the study of the humoral autoimmune response in human 
viral myocarditis. 
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